Upstream Bio are a biotechnology research company based out of Waltham, Massachusetts that is seeking to determine the source of inflammation and eradicate it.
Upstream Bio was looking for a reliable long term CMO partner who could provide rapid access to manufacturing slots due to expedited phase 1 timelines and support the manufacture of a clinical GMP batch of their UPB-101 liquid drug product and associated testing, QP GMP confirmation and storage and distribution of finished product.
In this case study we will illustrate how Symbiosis were able to assist with the immediate requirement for production and associated support services for this important drug therapy.
To find out more, please fill in the form below to access the case study.
Want to be the first to know about our latest capabilities and offerings? Subscribe for Exclusive Updates